financetom
Business
financetom
/
Business
/
Why Expedia (EXPE) Stock Is Falling
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Expedia (EXPE) Stock Is Falling
Mar 11, 2025 12:11 PM

Expedia Group Inc ( EXPE ) shares are trading lower by 7.6% to $163.14 during Tuesday's session. The decline comes amid a broader sell-off in travel-related stocks following Delta Air Lines Inc's ( DAL ) reduced revenue and profit guidance.

Delta's warning about softening travel demand has raised concerns across the industry, pressuring Expedia's ( EXPE ) stock as well. Additionally, American Airlines Group Inc ( AAL ) cut its first-quarter adjusted EPS outlook.

What To Know: Expedia ( EXPE ), a leading online travel agency, is highly sensitive to fluctuations in travel demand. The company generates revenue primarily from booking commissions, hotel reservations, and vacation packages.

Read Also: Trump Slaps 50% Tariff On Canadian Steel & Aluminum, Threatens Auto Industry

A slowdown in consumer travel spending, as suggested by Delta and American Airlines’ revised outlooks, could weigh on Expedia's ( EXPE ) future earnings.

Expedia's ( EXPE ) business model relies heavily on both leisure and business travel. Delta's report of declining corporate and leisure travel suggests that fewer consumers may be booking flights and hotels, directly impacting Expedia's ( EXPE ) platform.

The company's dependence on strong seasonal travel trends also means any prolonged weakness in consumer sentiment could dampen revenue growth.

A broader downturn in discretionary spending could further pressure bookings, raising concerns about the company's ability to sustain growth in a weakening travel environment.

Read Also: Nasdaq 100 Trades Below Its 200-Day Moving Average: History Says You Should Buy The Dip Now

How To Buy EXPE Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Expedia Group’s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, EXPE has a 52-week high of $207.73 and a 52-week low of $107.27.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Phillips 66 to Sell 25% Equity Interest in Rockies Express Pipeline to Tallgrass Unit
Phillips 66 to Sell 25% Equity Interest in Rockies Express Pipeline to Tallgrass Unit
Jun 14, 2024
08:45 AM EDT, 06/14/2024 (MT Newswires) -- Phillips 66 (PSX) said Friday it has agreed to sell its 25% non-operated common equity interest in Rockies Express Pipeline to a Tallgrass Energy (TGE) subsidiary for about $1.23 billion. The deal is expected to close Friday, Phillips 66 said. Price: 137.25, Change: -0.42, Percent Change: -0.31 ...
Blue Origin, SpaceX, United Launch Services Secure $5.6 Billion US Space Launch Contract
Blue Origin, SpaceX, United Launch Services Secure $5.6 Billion US Space Launch Contract
Jun 14, 2024
08:48 AM EDT, 06/14/2024 (MT Newswires) -- Amazon.com ( AMZN ) founder Jeff Bezos' Blue Origin, Tesla (TSLA) CEO Elon Musk's SpaceX, and United Launch Services, a joint venture between Lockheed Martin ( LMT ) and Boeing ( BA ) have been awarded up to $5.6 billion in Pentagon contracts for national security-related rocket launches, the Department of Defense said...
Johnson & Johnson Reports Positive Long-Term Results for Talvey in Multiple Myeloma Study
Johnson & Johnson Reports Positive Long-Term Results for Talvey in Multiple Myeloma Study
Jun 14, 2024
08:48 AM EDT, 06/14/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday that long-term data from an early-to-mid stage study of its drug, Talvey, to treat certain patients with multiple myeloma showed high overall response rates and durable responses, irrespective of prior T-cell redirection therapy. The company said the study showed that patients treated with the drug...
Market Chatter: Microsoft Plans to Invest $7.15 Billion to Build New Data Centers in Aragon, Spain
Market Chatter: Microsoft Plans to Invest $7.15 Billion to Build New Data Centers in Aragon, Spain
Jun 14, 2024
08:48 AM EDT, 06/14/2024 (MT Newswires) -- Microsoft ( MSFT ) plans to invest 6.69 billion euros ($7.15 billion) over a 10-year period for the development of new data centers in Spain's Aragon region, Reuters reported Friday. The company is seeking a permit for the construction of data centers at a location outside the city of Zaragoza, the report said,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved